
|Videos|April 4, 2019 (Updated: April 27, 2023)
Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma
Author(s)Ryan J. Sullivan, MD
Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.
Advertisement
Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC
2
Iza-Bren Yields Statistically Significant Efficacy in Advanced TNBC
3
Olaparib Combo Improves PFS/OS in BRCA+ or ATM+ Metastatic CRPC
4
Decoding Key Community Oncology Takeaways From ASCO GI 2026
5














































